Cases & Deals

Forbion Capital leads investment in Xention

Clients Forbion Capital Partners & other entities

Jones Day advised Forbion Capital Partners & other entities in connection with their purchase of Convertible Preferred Stock in a private placement by Xention Limited, a company that engages in the discovery and development of ion channel-modulating drugs in the United Kingdom.